Unlike bariatric surgery, medical weight loss programs focus on customized plans that include nutrition counseling, lifestyle coaching, and medications to support safe and sustainable results
[Accessed on 11 June 2026] Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial (2023)
J., Greenhaff, P
"I guess it's just quite enticing, because you're talking to people who are using it who are like, 'Oh my God, it's like transformative, and my skin's amazing, and I've lost all this weight,'" she said
If symptoms are severe, your doctor may delay dose escalation, reduce the dose, or review whether the medicine is suitable for you
Research indicates that semaglutide use is associated with an increased risk of gallbladder-related complications, including gallstone formation (cholelithiasis) and inflammation of the gallbladder (cholecystitis)